Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Phcog.Net JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS Volume 5 · Issue 3 2014 · pp. 122–224
    Search this issue

    Cover: Journal of Pharmacology and Pharmacotherapeutics

    Journal of Pharmacology and Pharmacotherapeutics

    Volume 5, Issue 3

    2014 · pp. 122–224 · 14 articles

    Volume
    5
    Issue
    3
    Published
    2014
    Pages
    122–224
    Articles
    14
    Sections
    9
    ISSN
    ISSN: Print - 0976-500X, Online - 0976-5018
    Journal
    J Pharmacol. Pharmacother.

    In this issue

    News and Views

    1. Article

      New(s): Are these terms new(s)!?

      G. Sivagnanam

      pp. 220–221 · DOI: 10.4103/0976-500X.136116 · Published 2014

    Editorial

    1. Forum Article

      [Downloaded free from http://www.jpharmacol.com on Wednesday, October 13, 2021, IP: 157.45.222.78]

      Raveendran: Animal experimentation in postgraduate training Journal of Pharmacology and Pharmacotherapeutics | July-September | Vol | Issue

      pp. 179–180 · DOI: 10.4103/0976-500X.136095 · Published 2014

      The article with the headline “Medical Council of India (MCI) likely to ban animal dissection at post‑grad level too” in the Pioneer, a New Delhi based daily came as a rude shock to some of us (http://www.dailypioneer.co

    Mini Review

    1. Article

      Statin induced diabetes and its clinical implications

      Umme Aiman, Ahmad Najmi, Rahat Ali Khan

      pp. 181–185 · DOI: 10.4103/0976-500X.136097 · Published 2014

      Statins are one of the most commonly used drugs in the world based on their potential to prevent adverse cardiovascular events. These cholesterol‑lowering drugs received a US Food and Drug Administration warning, in Febr

    Review Article

    1. Review

      Metronomic chemotherapy

      Rituparna Maiti

      pp. 186–192 · DOI: 10.4103/0976-500X.136098 · Published 2014

      Toxic effects and chemoresistance are major hurdles in chemotherapy and to avoid these problems caused by traditional chemotherapeutic regimens, a new modality of drug administration called “metronomic chemotherapy” has

    Research Paper

    1. Article

      Effects of glucocorticoids and tumor necrosis factor‑alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis

      Raffaele Serra, Raffaele Grande, Gianluca Buffone, Edoardo Scarcello, Fabio Tripodi, Pierandrea Rende, Luca Gallelli, Stefano de Franciscis

      pp. 193–196 · DOI: 10.4103/0976-500X.136101 · Published 2014

      Objective: To explore the effect of sequential treatment with glucocorticoid and tumor necrosis factor‑alpha inhibitors in patients with Takayasu arteritis (TA). Materials and Methods: In five patients with TA, the effec

    2. Article

      Antidepressant‑like effect of a novel 5‑HT3 receptor antagonist N‑(benzo[d] thiazol‑2‑yl)‑3‑ethoxyquinoxalin‑2‑carboxamide 6k using rodents behavioral battery tests

      Yeshwant Kurhe, Radhakrishnan Mahesh, Thangaraj Devadoss, Deepali Gupta

      pp. 122–123 · DOI: 10.4103/0976-500X.136104 · Published 2010

      Objective: To investigate the antidepressant‑like effect of N‑(benzo[d] thiazol‑2‑yl)‑3‑ ethoxyquinoxalin‑2‑carboxamide 6k, a 5‑hydroxytryptamine type 3 (5‑HT3) receptor antagonist using rodents behavioral battery tests.

    Research Letter

    1. Article

      Cannabis use among opioid-dependent individuals on opioid substitution therapy

      Yatan Pal Singh Balhara, Raka Jain

      pp. 203–205 · DOI: 10.4103/0976-500X.136106 · Published 2014

      The findings of this study suggest that a significant proportion of individuals on OST tested positive for cannabis. It is therefore recommended to use urinalysis during OST to monitor ongoing use of cannabis. Detection

    2. Article

      Sexual dysfunction in alcohol-dependent men on disulfiram or baclofen prophylaxis: A preliminary report

      Sandeep Grover, Siddharth Sarkar, Naresh Nebhinani, Surendra K. Mattoo, Debasish Basu

      pp. 205–207 · DOI: 10.4103/0976-500X.136108 · Published 2014

      The alcohol use disorders and sexual functioning have a complex relationship. Alcohol use has been suggested to enhance desire of sexual activity and indulgence in riskier sex. Use of alcohol has also been linked with im

    Case Report

    1. Article

      Hirsutism following the use of bimatoprost eyedrops for glaucoma

      Subashini Kaliaperumal, Indu Govindaraj, Praveen Kumar Kopparapu, Shashi Ahuja

      pp. 208–210 · DOI: 10.4103/0976-500X.136110 · Published 2014

      Prostaglandin F2 alpha (PGF2α) analogues including bimatoprost are often the first line drugs used in the treatment of glaucoma. We present a case of a 62‑year‑old female patient who was started on bimatoprost in both th

    2. Article

      Netilmicin‑induced carpopedal spasm

      Roja Y. Ramani, Benu Panigrahy, Bandana Rath

      pp. 211–213 · DOI: 10.4103/0976-500X.136112 · Published 2014

      Aminoglycoside‑induced nephrotoxicity is not uncommon. Netilmicin being a member of gentamicin family has the advantage of being relatively free from ototoxicity and nephrotoxicity and is also prescribed for gentamicin r

    3. Article

      Angioedema due to fixed dose combination of telmisartan plus ramipril

      Vishal R. Tandon, Annil Mahajan, Vijay Khajuria, Zahid H. Gillani

      pp. 214–216 · DOI: 10.4103/0976-500X.136113 · Published 2014

      The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin‑converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema wit

    4. Article

      Acute delirium in an elderly woman following zoledronate administration

      Mohammad Nasiruddin, Mohd Fayazuddin, Mohammad Zahid, Syed Iftekhar

      pp. 217–219 · DOI: 10.4103/0976-500X.136115 · Published 2014

      Zoledronate is a third‑generation bisphosphonate having distinctive profile of high potency as well as prolonged duration of action. Intravenous zoledronate is the recently approved bisphosphonate for the treatment of os

    News and review

    1. Article

      News and review

      pp. 220–220 · DOI: · Published 2014

      The Trial to Assess Chelation Therapy (TACT) was a study (a 10‑year, $31.6‑million study involving 1,708 participants at 134 centers) that involved an intervention of EDTA‑based infusion regimen in patients aged ≥50 year

    Molecules of the Millennium

    1. Article

      Delamanid: A new armor in combating drug‑resistant tuberculosis

      Alphienes Stanley Xavier, Mageshwaran Lakshmanan

      pp. 222–224 · DOI: 10.4103/0976-500X.136121 · Published 2014

      Intense search has been made in the discovery of newer anti‑TB drugs to tackle the issues such as drug resistance, HIV co‑infection and risk of drug‑drug interactions in the management of TB. Delamanid, a newer mycobacte